Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhancing the Use of Secondary Prevention Strategies in Patients With Coronary Artery Disease (The ESP-CAD Study)

NCT00175240 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT00175240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00175240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhancing the Use of Secondary Prevention Strategies in Patients With Coronary Artery Disease (The ESP-CAD Study)
Lead sponsor
University of Alberta
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2005
Completion date
July 31, 2015
Enrollment
480 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary disease, ischemic heart disease